Journal of Molecular and Clinical Medicine (JMCM) is a peer-reviewed, open access journal publishing papers reporting on original studies in basic biological, pre-clinical as well as clinical research in all disciplines of molecular and cellular biomedical research with potential implications for translational medicine.

Aims and Scope
Journal of Molecular and Clinical Medicine (JMCM) aims at publishing original molecular and cellular studies in the general areas of biological, pre-clinical, and clinical research. It is hoped that these novel findings will further our current knowledge of the mechanisms underlying key biological and physiological processes as well as pathological states, possibly leading to new translational medicine endpoints and therapeutic avenues.

Open Access Publishing

JMCM is an open access journal published by IMR press. IMR publishes all of our journals using a Open Access model. All articles published in IMR journals are available to readers completely free of charge. For the authors who submit and publish papers with IMR press, 1500US dollars will be required for publication as the article processing fee. However, there is no fee for the invited high-quality articles. Your article will become available immediately upon publication in JMCM, you will retain copyright of your article and a Creative Commons license will be applied. At this time we allow authors to choose between the Creative Commons (CC BY) license and CC BY-Noncommercial (CC BY-NC) license.

CC-BY License The CC BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

CC-BY-Non-Commercial License The CC BY-NC license permits any noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

Any users will be permitted to read, download, copy, distribute, print, search, or link to the full texts of these Open Access articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself.

Open Access is a reaction to the traditional, subscription-based model of scholarly publishing. Under the subscription system, anyone wishing to read an article has to pay a fee to the publisher. At an institutional level this is usually arranged by the library, which agrees to pay the publisher in order for its members to have access to relevant journals. Subscriptions originally would have involved the physical delivery of printed copies of the journal, but today’s publishers have almost entirely adopted digital delivery. More recently, subscriptions have involved bulk journal packages with large publishers, commonly referred to as ‘big deals’.

When institutional access is not available, individual readers may have to purchase access to journals – or specific articles – themselves at significant personal cost. With a subscription model, researchers and institutions have to carefully consider how they allocate funds. Many articles remain locked behind paywalls, limiting access to only the largest institutions and denying access to the general public. This causes frustration and, more importantly, hampers scientific progress. This model causes gaps to appear between institutions with different levels of funding and disadvantages researchers from developing regions.

Public money and charitable organizations fund most current academic research. In effect, this model makes readers purchase access to materials that they helped fund through government spending and charitable donations.

By using a liberal copyright license, Open Access removes barriers and allows researchers to make use of articles in new ways. This includes practices like meta-analysis and text mining, which help reveal trends in science that would not be obvious at the level of individual articles.